Relationship between body composition and PBRM1 mutations in clear cell renal cell carcinoma: a propensity score matching analysis
- PMID: 37222312
- PMCID: PMC10204845
- DOI: 10.1590/1806-9282.20220415
Relationship between body composition and PBRM1 mutations in clear cell renal cell carcinoma: a propensity score matching analysis
Abstract
Objective: This study aimed to examine the relationship between body muscle and adipose tissue composition in clear cell renal cell carcinoma patients with PBRM1 gene mutation.
Methods: Cancer Genome Atlas Kidney clear cell renal cell carcinoma and Clinical Proteomic Tumor Analysis Consortium clear cell renal cell carcinoma collections were retrieved from the Cancer Imaging Archive. A total of 291 clear cell renal cell carcinoma patients were included in the study retrospectively. Patients' characteristics were obtained from Cancer Imaging Archive. Body composition was assessed with abdominal computed tomography using the automated artificial intelligence software (AID-U™, iAID Inc., Seoul, Korea). Body composition parameters of the patients were calculated. To investigate the net effect of body composition, the propensity score matching procedure was applied over age, gender, and T-stage parameters.
Results: Of the patients, 184 were males and 107 were females. Mutations in the PBRM1 gene were detected in 77 of the patients. While there was no difference in adipose tissue areas between the PBRM1 mutation group and those without PBRM1 mutation, statistically significant differences were found in normal attenuated muscle area parameters.
Conclusion: This study shows that there was no difference between adipose tissue areas in patients with PBMR1 mutation, but normal attenuated muscle area was found to be higher in PBRM1 patients.
Conflict of interest statement
Conflicts of interest: the authors declare there is no conflicts of interest.
Similar articles
-
Comments on "Relationship between body composition and PBRM1 mutations in clear cell renal cell carcinoma: a propensity score matching analysis".Rev Assoc Med Bras (1992). 2023 Sep 18;69(9):e20230721. doi: 10.1590/1806-9282.20230721. eCollection 2023. Rev Assoc Med Bras (1992). 2023. PMID: 37729382 Free PMC article. No abstract available.
-
Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation.Lancet Oncol. 2013 Feb;14(2):159-167. doi: 10.1016/S1470-2045(12)70584-3. Epub 2013 Jan 16. Lancet Oncol. 2013. PMID: 23333114 Free PMC article.
-
Radiogenomics in Clear Cell Renal Cell Carcinoma: Machine Learning-Based High-Dimensional Quantitative CT Texture Analysis in Predicting PBRM1 Mutation Status.AJR Am J Roentgenol. 2019 Mar;212(3):W55-W63. doi: 10.2214/AJR.18.20443. Epub 2019 Jan 2. AJR Am J Roentgenol. 2019. PMID: 30601030
-
BAP1, PBRM1 and SETD2 in clear-cell renal cell carcinoma: molecular diagnostics and possible targets for personalized therapies.Expert Rev Mol Diagn. 2015;15(9):1201-10. doi: 10.1586/14737159.2015.1068122. Epub 2015 Jul 11. Expert Rev Mol Diagn. 2015. PMID: 26166446 Review.
-
Genomics and clinical correlates of renal cell carcinoma.World J Urol. 2018 Dec;36(12):1899-1911. doi: 10.1007/s00345-018-2429-x. Epub 2018 Aug 11. World J Urol. 2018. PMID: 30099580 Free PMC article. Review.
Cited by
-
Comments on "Relationship between body composition and PBRM1 mutations in clear cell renal cell carcinoma: a propensity score matching analysis".Rev Assoc Med Bras (1992). 2023 Sep 18;69(9):e20230721. doi: 10.1590/1806-9282.20230721. eCollection 2023. Rev Assoc Med Bras (1992). 2023. PMID: 37729382 Free PMC article. No abstract available.
-
A Scoping Review of Population Diversity in the Common Genomic Aberrations of Clear Cell Renal Cell Carcinoma.Oncology. 2025;103(4):341-350. doi: 10.1159/000541370. Epub 2024 Sep 9. Oncology. 2025. PMID: 39250899 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous